Prevalence and factors associated with hyperglycemia among persons living with HIV/AIDS on dolutegravir-based antiretroviral therapy in Uganda.
Lillian Happy ByeretaRonald OlumEdrisa Ibrahim MutebiRobert KalyesubulaMajid KagimuDavid B MeyaIrene Andia-BiraroPublished in: Therapeutic advances in infectious disease (2024)
More than 1 in 10 patients on DTG-based ART in our study had hyperglycemia. We recommend regular monitoring of plasma glucose, especially for patients >40 years old and those with other comorbidities, before starting/switching to DTG regimens. Longitudinal studies are recommended to determine the underlying mechanisms of hyperglycemia in this population.
Keyphrases
- antiretroviral therapy
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- hiv infected
- prognostic factors
- type diabetes
- risk factors
- hiv infected patients
- blood pressure
- hiv positive
- hiv aids
- cross sectional
- adipose tissue
- south africa
- skeletal muscle
- blood glucose
- weight loss
- insulin resistance
- men who have sex with men